Hassan M. Otifi

Abha, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

The association between global and prime diet quality scores and the risk of breast cancer: a case control study.

The association between global and prime diet quality scores and the risk of breast cancer: a case control study.

Journal: Frontiers in public health

Published: November 28, 2025

Correction: Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential.

Correction: Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential.

Journal: Discover oncology

Published: October 23, 2025

In-Silico identification and optimization of therapeutic peptides against breast cancer via transcriptomic profiling.

In-Silico identification and optimization of therapeutic peptides against breast cancer via transcriptomic profiling.

Journal: Molecular diversity

Published: October 01, 2025

Nepetin attenuates sertraline-induced cardiac dysfunction by modulating notch signaling, oxidative stress, and inflammation: Echocardiographic and histological evidence.

Nepetin attenuates sertraline-induced cardiac dysfunction by modulating notch signaling, oxidative stress, and inflammation: Echocardiographic and histological evidence.

Journal: Tissue & cell

Published: August 19, 2025

Nephroprotective Potential of Tectorigenin Against Thiamethoxam Instigated Renal Toxicity Via Regulating HMGB1/RAGE, TLR4/MyD88, and NF-κB Pathway in Sprague Dawley Rats: An In-Vivo and In-Silico Investigation.

Nephroprotective Potential of Tectorigenin Against Thiamethoxam Instigated Renal Toxicity Via Regulating HMGB1/RAGE, TLR4/MyD88, and NF-κB Pathway in Sprague Dawley Rats: An In-Vivo and In-Silico Investigation.

Journal: Journal of biochemical and molecular toxicology

Published: May 28, 2025

Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential.

Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential.

Journal: Discover oncology

Published: May 28, 2025

Fenthion Triggers Cardiac Dysfunction Through TLR4, HMGB1/RAGE, and NF-κB Pathways: An In Vivo and In Silico Assessment.

Fenthion Triggers Cardiac Dysfunction Through TLR4, HMGB1/RAGE, and NF-κB Pathways: An In Vivo and In Silico Assessment.

Journal: Journal of applied toxicology : JAT

Published: April 26, 2025

ALG3 as a PanCancer Oncogene: Bioinformatics Analysis and Identification of Small-Molecule Inhibitors.

ALG3 as a PanCancer Oncogene: Bioinformatics Analysis and Identification of Small-Molecule Inhibitors.

Journal: Anti-cancer agents in medicinal chemistry

Published: April 21, 2025

Syringetin ameliorates thallium sulphate induced renal dysfunction via regulating Nrf2/Keap-1, TLR4/HMGB1/RAGE and NF-κB pathway.

Syringetin ameliorates thallium sulphate induced renal dysfunction via regulating Nrf2/Keap-1, TLR4/HMGB1/RAGE and NF-κB pathway.

Journal: Tissue & cell

Published: March 25, 2025

Synthesis, characterization, and toxicity evaluation of ciprofloxacin-chloranilic acid charge transfer complexes: potential for anticancer applications.

Synthesis, characterization, and toxicity evaluation of ciprofloxacin-chloranilic acid charge transfer complexes: potential for anticancer applications.

Journal: RSC medicinal chemistry

Published: January 28, 2025

Targeting the Inactive Conformation of the Epidermal Growth Factor Receptor Identifies EG31: A Novel Small Molecule Inhibitor Effective Against Normal and 5-Fluorouracil-Resistant Triple Negative Breast Cancer Cells.

Targeting the Inactive Conformation of the Epidermal Growth Factor Receptor Identifies EG31: A Novel Small Molecule Inhibitor Effective Against Normal and 5-Fluorouracil-Resistant Triple Negative Breast Cancer Cells.

Journal: OncoTargets and therapy

Published: December 14, 2024

Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups.

Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups.

Journal: European journal of histochemistry : EJH

Published: December 14, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026